Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Cellular Immunology
|
November 2, 2020
NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytes
Kazunori Nakayama, Hideya Onishi, Akiko Fujimura, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
April 25, 2012
A translocator protein ligand PK11195 shows antigrowth activity in human choriocarcinoma cells
Noriyuki Takai, Naoko Kira, Terukazu Ishii, et al.
Anticancer Research
|
May 31, 2022
PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer
Hideya Onishi, Naoya Iwamoto, Keita Sakanashi, et al.
Anticancer Research
|
June 23, 2023
MAML3 Contributes to Induction of Malignant Phenotype of Gallbladder Cancer Through Morphogenesis Signalling Under Hypoxia
Lin Na, Hideya Onishi, Shinji Morisaki, et al.
Journal of Cancer Research and Clinical Oncology
|
August 16, 2023
PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy target
Naoya Iwamoto, Hideya Onishi, Shogo Masuda, et al.
Journal of Cancer
|
March 5, 2020
FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients
Kiyoshi Saeki, Hideya Onishi, Satoko Koga, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 14, 2019
Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy
Yasuhiro Oyama, Hideya Onishi, Satoko Koga, et al.
International Journal of Surgery Case Reports
|
April 25, 2017
Eosinophilic funiculitis initially diagnosed as irreducible inguinal hernia: A case report
Kohei Yamada, Akashi Ikubo, Shota Ikeda, et al.
Translational Oncology
|
June 16, 2021
PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor
Satoko Koga, Hideya Onishi, Shogo Masuda, et al.
Japanese Journal of Clinical Oncology
|
April 7, 2004
Absence of mutations in the Wilms' tumor gene WT1 in primary breast cancer
Yusuke Oji, Yasuo Miyoshi, Eiji Kiyotoh, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Cellular Immunology
|
November 2, 2020
NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytes
Kazunori Nakayama, Hideya Onishi, Akiko Fujimura, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
April 25, 2012
A translocator protein ligand PK11195 shows antigrowth activity in human choriocarcinoma cells
Noriyuki Takai, Naoko Kira, Terukazu Ishii, et al.
Anticancer Research
|
May 31, 2022
PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer
Hideya Onishi, Naoya Iwamoto, Keita Sakanashi, et al.
Anticancer Research
|
June 23, 2023
MAML3 Contributes to Induction of Malignant Phenotype of Gallbladder Cancer Through Morphogenesis Signalling Under Hypoxia
Lin Na, Hideya Onishi, Shinji Morisaki, et al.
Journal of Cancer Research and Clinical Oncology
|
August 16, 2023
PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy target
Naoya Iwamoto, Hideya Onishi, Shogo Masuda, et al.
Journal of Cancer
|
March 5, 2020
FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients
Kiyoshi Saeki, Hideya Onishi, Satoko Koga, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 14, 2019
Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy
Yasuhiro Oyama, Hideya Onishi, Satoko Koga, et al.
International Journal of Surgery Case Reports
|
April 25, 2017
Eosinophilic funiculitis initially diagnosed as irreducible inguinal hernia: A case report
Kohei Yamada, Akashi Ikubo, Shota Ikeda, et al.
Translational Oncology
|
June 16, 2021
PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor
Satoko Koga, Hideya Onishi, Shogo Masuda, et al.
Japanese Journal of Clinical Oncology
|
April 7, 2004
Absence of mutations in the Wilms' tumor gene WT1 in primary breast cancer
Yusuke Oji, Yasuo Miyoshi, Eiji Kiyotoh, et al.
Page
of 3